{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:31:13Z","timestamp":1793723473716,"version":"4.6.1"},"reference-count":155,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2020,3,3]]},"DOI":"10.1080\/14760584.2020.1738226","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T09:56:38Z","timestamp":1584698198000},"page":"247-265","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":18,"title":["Ten years of experience with the pneumococcal non-typeable\n                    <i>Haemophilus influenzae<\/i>\n                    protein D-conjugate vaccine (\n                    <i>Synflorix<\/i>\n                    ) in children"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0321-6283","authenticated-orcid":false,"given":"Nicolas","family":"Lecrenier","sequence":"first","affiliation":[{"name":"GSK Vaccines, GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1046-9702","authenticated-orcid":false,"given":"Alen","family":"Marijam","sequence":"additional","affiliation":[{"name":"GSK Vaccines, GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8485-5748","authenticated-orcid":false,"given":"Jan","family":"Olbrecht","sequence":"additional","affiliation":[{"name":"GSK Vaccines, GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2166-7926","authenticated-orcid":false,"given":"Lamine","family":"Soumahoro","sequence":"additional","affiliation":[{"name":"GSK Vaccines, GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3073-2830","authenticated-orcid":false,"given":"Javier","family":"Nieto Guevara","sequence":"additional","affiliation":[{"name":"GSK Vaccines, GSK","place":["Panama City, Panama"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6772-1633","authenticated-orcid":false,"given":"Bruce","family":"Mungall","sequence":"additional","affiliation":[{"name":"GSK Vaccines, GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,3,20]]},"reference":[{"issue":"8","key":"e_1_3_7_3_1","first-page":"85","article-title":"Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper \u2013 February 2019","volume":"94","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper \u2013 February 2019. Wkly Epidemiol Rec. 2019;94(8):85\u2013104.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61204-6"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30247-X"},{"key":"e_1_3_7_6_1","unstructured":"Cohen O Knoll M O\u2019Brien K et al. Pneumococcal Conjugate Vaccine (PCV) product assessment; [cited 2019 Aug 23]. Available from: https:\/\/www.jhsph.edu\/ivac\/wp-content\/uploads\/2018\/05\/pcv-product-assessment-april-25-2017.pdf"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001517"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2.5.619"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-47-7-563"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2002.01124.x"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008480-199302000-00009"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(96)92081-2"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.06.044"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1086\/313608"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200003000-00003"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200209000-00005"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102083440602"},{"issue":"42","key":"e_1_3_7_18_1","first-page":"1148","article-title":"Progress in introduction of pneumococcal conjugate vaccine\u2013worldwide, 2000\u20132008","volume":"57","author":"Centers for Disease Control and Prevention (CDC)","year":"2008","unstructured":"Centers for Disease Control and Prevention (CDC). Progress in introduction of pneumococcal conjugate vaccine\u2013worldwide, 2000\u20132008. MMWR Morb Mortal Wkly Rep. 2008;57(42):1148\u20131151.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.09.009"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70083-9"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318187e215"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000143640.03214.18"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.59.4.1231-1238.1991"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00288-7"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.9.5383-5391.2004"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.06.026"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1333905"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ695"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001601"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2019.06.010"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2011.05.014"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000148233.57296.90"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68304-9"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.03.017"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.12.008"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.09.113"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00230-5"},{"key":"e_1_3_7_38_1","unstructured":"World Health Organization. WHO Technical Report Series No. 977 Annex 3. Recommendations to assure the quality safety and efficacy of pneumococcal conjugate vaccines. Replacement of WHO Technical Report Series No. 927 Annex 2; [cited 2019 Jun 19]. Available from: http:\/\/www.who.int\/biologicals\/expert_committee\/TRS_977_60th_report.pdf?ua=1"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v36i00a12"},{"key":"e_1_3_7_40_1","unstructured":"European Medicines Agency. Assessment report for synflorix; [cited 2019 Jun 19]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/synflorix-epar-public-assessment-report_en.pdf"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318199f8ef"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318199f901"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318199f62d"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182323ac2"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318199f61b"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.7.5.14634"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61208-3"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181b48ca3"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31821d1790"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181dffabf"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318199f609"},{"issue":"35","key":"e_1_3_7_52_1","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1016\/j.vaccine.2008.05.080","article-title":"Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines","volume":"26","author":"Prymula R","year":"2008","unstructured":"Prymula R, Chlibek R, Splino M, et al. Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines. Vaccine. 2008;26(35):4563\u20134570.","journal-title":"Vaccine"},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.12.007"},{"key":"e_1_3_7_54_1","unstructured":"European Medicines Agency. Synflorix: procedural steps taken and scientific information after the authorisation; [cited 2019 Jun 19]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/procedural-steps-after\/synflorix-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001657"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70060-8"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120290"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005881"},{"key":"e_1_3_7_59_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-1184"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001518"},{"key":"e_1_3_7_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.08.039"},{"key":"e_1_3_7_62_1","unstructured":"European Medicines Agency. Synflorix - summary of product characteristics; [cited 2019 Aug 23]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/synflorix-epar-product-information_en.pdf"},{"key":"e_1_3_7_63_1","unstructured":"World Health Organization. Prequalification of one- and two-dose presentations of preservative-free 10-valent pneumococcal conjugate vaccine from GlaxoSmithKline (GSK) (Synflorix\u2122); [cited 2019 Jun19]. Available from: https:\/\/www.who.int\/immunization_standards\/vaccine_quality\/synflorix_pqnote\/en\/"},{"key":"e_1_3_7_64_1","unstructured":"World Health Organization. WHO prequalified vaccines - pneumococcal (conjugate) \u2013 Synflorix; [cited 2019 Jun 19]. Available from: https:\/\/extranet.who.int\/gavi\/PQ_Web\/PreviewVaccine.aspx?nav=0&ID=341"},{"key":"e_1_3_7_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.12.034"},{"key":"e_1_3_7_66_1","unstructured":"World Health Organization. WHO policy statement: Multi-dose vial policy (MDVP) - revision 2014 - handling of multi-dose vacccine vials after opening; [cited 2019 Jun 19]. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/135972\/1\/WHO_IVB_14.07_eng.pdf"},{"key":"e_1_3_7_67_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2016.1164044"},{"key":"e_1_3_7_68_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1287640"},{"key":"e_1_3_7_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.08.020"},{"key":"e_1_3_7_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61854-6"},{"key":"e_1_3_7_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70338-4"},{"key":"e_1_3_7_72_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000857"},{"key":"e_1_3_7_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70139-0"},{"key":"e_1_3_7_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.05.033"},{"key":"e_1_3_7_75_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piw010"},{"key":"e_1_3_7_76_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166736"},{"key":"e_1_3_7_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.09.005"},{"key":"e_1_3_7_78_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1320221"},{"key":"e_1_3_7_79_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1516551"},{"key":"e_1_3_7_80_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212295"},{"key":"e_1_3_7_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2017.07.009"},{"key":"e_1_3_7_82_1","unstructured":"Cohen O Knoll M O\u2019Brien K et al. Pneumococcal Conjugate Vaccine (PCV) review of impact evidence (PRIME): summary of findings from systematic review October 2017; [cited 2019 Aug 23]. Available from: https:\/\/www.who.int\/immunization\/sage\/meetings\/2017\/october\/3_FULL_PRIME_REPORT_2017Sep26.pdf?ua=1"},{"key":"e_1_3_7_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2018.12.007"},{"key":"e_1_3_7_84_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210081"},{"key":"e_1_3_7_85_1","first-page":"e155","article-title":"Impact of the 10-valent pneumococcal conjugate vaccine on the southern area of Santiago (Chile), 2009\u20132015Efeito da vacina pneumococica 10-valente conjugada na regiao sul de Santiago, Chile, 2009\u20132015","volume":"42","author":"Alvarado S","year":"2018","unstructured":"Alvarado S, Cavada G, Villena R, et al. Impact of the 10-valent pneumococcal conjugate vaccine on the southern area of Santiago (Chile), 2009\u20132015Efeito da vacina pneumococica 10-valente conjugada na regiao sul de Santiago, Chile, 2009\u20132015. Rev Panam Salud Publica. 2018;42:e155.","journal-title":"Rev Panam Salud Publica"},{"key":"e_1_3_7_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.11.054"},{"key":"e_1_3_7_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)33005-8"},{"key":"e_1_3_7_88_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy570"},{"key":"e_1_3_7_89_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2017.22.10.30481"},{"key":"e_1_3_7_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.10.090"},{"issue":"3","key":"e_1_3_7_91_1","first-page":"e00131414","article-title":"Impact of PCV10 pneumococcal vaccine on mortality from pneumonia in children less than one year of age in Santa Catarina State, Brazil","volume":"32","author":"Kupek E","year":"2016","unstructured":"Kupek E, Vieira IL. Impact of PCV10 pneumococcal vaccine on mortality from pneumonia in children less than one year of age in Santa Catarina State, Brazil. Cad Saude Publica. 2016;32(3):e00131414.","journal-title":"Cad Saude Publica"},{"key":"e_1_3_7_92_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix850"},{"key":"e_1_3_7_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30455-8"},{"key":"e_1_3_7_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30491-1"},{"issue":"4","key":"e_1_3_7_95_1","first-page":"418","article-title":"Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children","volume":"34","author":"Silva SR","year":"2016","unstructured":"Silva SR, Mello LM, Silva AS, et al. Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children. Rev Paul Pediatr. 2016;34(4):418\u2013424.","journal-title":"Rev Paul Pediatr"},{"issue":"4","key":"e_1_3_7_96_1","first-page":"e2017378","article-title":"The impact of pneumococcal vaccine in reducing pneumonia hospitalizations in children under 5 years old, in Santa Catarina, Brazil, 2006 a 2014","volume":"27","author":"Vieira ILV","year":"2018","unstructured":"Vieira ILV, Kupek E. The impact of pneumococcal vaccine in reducing pneumonia hospitalizations in children under 5 years old, in Santa Catarina, Brazil, 2006 a 2014. Epidemiol Serv Saude. 2018;27(4):e2017378.","journal-title":"Epidemiol Serv Saude"},{"key":"e_1_3_7_97_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix638"},{"key":"e_1_3_7_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.01.064"},{"key":"e_1_3_7_99_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020619"},{"key":"e_1_3_7_100_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001870"},{"key":"e_1_3_7_101_1","doi-asserted-by":"publisher","DOI":"10.1111\/apa.14724"},{"key":"e_1_3_7_102_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3416-y"},{"key":"e_1_3_7_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.026"},{"key":"e_1_3_7_104_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01046-18"},{"key":"e_1_3_7_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.07.008"},{"key":"e_1_3_7_106_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001810"},{"key":"e_1_3_7_107_1","unstructured":"Finnish National Institute for Health and Welfare (THL). Incidence of invasive pneumococcal disease in Finland; [cited 2019 Jun 7]. Available from: https:\/\/thl.fi\/en\/web\/thlfi-en\/research-and-expertwork\/projects-and-programmes\/monitoring-the-population-effectiveness-of-pneumococcal-conjugate-vaccination-in-the-finnish-national-vaccination-programme\/incidence-of-invasive-pneumococcal-disease-in-finland"},{"key":"e_1_3_7_108_1","unstructured":"Institudo de Salud Publica. Vigilancia de Laboratorio de Streptococcus pneumoniae procedente de Enfermedad Invasora. Chile 2007 \u2013 2015; [cited 2019 Jun 7]. Available from: http:\/\/www.ispch.cl\/sites\/default\/files\/Bolet%C3%ADn%20de%20Vigilancia%20de%20Laboratorio%20de%20Streptococcus%20pneumoniae.pdf"},{"key":"e_1_3_7_109_1","unstructured":"Institudo de Salud Publica. Vigilancia de Laboratorio de Streptococcus pneumoniae procedente de Enfermedad Invasora. Chile 2011 \u2013 2017; [cited 2019 Jun 7]. Available from: http:\/\/www.ispch.cl\/sites\/default\/files\/BoletinNeumo-08012019B%20(1).pdf"},{"key":"e_1_3_7_110_1","unstructured":"National Institute for Public Health and the Environment. The national immunisation programme in the Netherlands: surveillance and developments in 2017\u20132018; [cited 2019 Jun 7]. Available from: https:\/\/www.rivm.nl\/bibliotheek\/rapporten\/2018-0124.pdf"},{"key":"e_1_3_7_111_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix685"},{"key":"e_1_3_7_112_1","unstructured":"ESR. Invasive pneumococcal disease quarterly report October\u2013December 2018 and Annual Report 2010; [cited 2019 Aug 14]. Available from: https:\/\/surv.esr.cri.nz\/surveillance\/IPD.php"},{"key":"e_1_3_7_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.07.006"},{"key":"e_1_3_7_114_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182787f89"},{"key":"e_1_3_7_115_1","volume-title":"5th ESCMID Conference on Vaccines","author":"Marijam A","year":"2019","unstructured":"Marijam A, Schuerman L, Izurieta P et al. Estimated impact of pneumococcal nontypeable Haemophilus influenzae polysaccharide protein D conjugate vaccine (PHiD-CV) and human rotavirus vaccine (HRV) on child morbidity and mortality. 5th ESCMID Conference on Vaccines; 2019; Bilbao, Spain. Available at: https:\/\/www.escmid.org\/escmid_publications\/escmid_elibrary\/material\/?mid=71693"},{"key":"e_1_3_7_116_1","unstructured":"International Vaccine Access Center (IVAC). PCV - vaccine introduction - current dosing schedule; [cited 2019 Feb]. Available from: http:\/\/www.view-hub.org.\/viz\/"},{"key":"e_1_3_7_117_1","unstructured":"GAVI. Detailed product profiles; [cited 2019 Feb]. Available from: https:\/\/www.gavi.org\/about\/market-shaping\/detailed-product-profiles\/"},{"issue":"1","key":"e_1_3_7_118_1","first-page":"010401","article-title":"Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries","volume":"3","author":"Rudan I","year":"2013","unstructured":"Rudan I, O\u2019Brien KL, Nair H, et al. Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health. 2013;3(1):010401.","journal-title":"J Glob Health"},{"key":"e_1_3_7_119_1","unstructured":"Russell F Sanderson C Temple B et al. Global review of the distribution of pneumococcal disease by age and region [cited 2011 Oct]. Available from: https:\/\/www.who.int\/immunization\/sage\/6_Russel_review_age_specific_epidemiology_PCV_schedules_session_nov11.pdf"},{"key":"e_1_3_7_120_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00402-10"},{"key":"e_1_3_7_121_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2013.852475"},{"key":"e_1_3_7_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.06.011"},{"key":"e_1_3_7_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.03.014"},{"key":"e_1_3_7_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.01.081"},{"issue":"9","key":"e_1_3_7_125_1","doi-asserted-by":"crossref","first-page":"A737","DOI":"10.1016\/j.jval.2017.08.2028","article-title":"A uniform probabilistic approach to manage uncertainties regarding vaccine effectiveness against serotype 3, 19A, NTHi and herd effect in the base case of a cost-effectiveness analysis comparing non-typeable Haemophilus influenzae protein D (PHiD-CV) with 13-valent pneumococcal conjugate vaccines (PCV13) in infants","volume":"20","author":"Olbrecht J","year":"2017","unstructured":"Olbrecht J, Simone B, Izurieta P. A uniform probabilistic approach to manage uncertainties regarding vaccine effectiveness against serotype 3, 19A, NTHi and herd effect in the base case of a cost-effectiveness analysis comparing non-typeable Haemophilus influenzae protein D (PHiD-CV) with 13-valent pneumococcal conjugate vaccines (PCV13) in infants. Value Health. 2017;20(9):A737\u2013A738.","journal-title":"Value Health"},{"key":"e_1_3_7_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.04.1183"},{"key":"e_1_3_7_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30310-4"},{"key":"e_1_3_7_128_1","unstructured":"International Vaccine Access Center (IVAC). PCV - vaccine coverage - WUENIC coverage rates; [cited 2019 Jun 19]. Available from: http:\/\/www.view-hub.org.\/viz\/"},{"key":"e_1_3_7_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31084-0"},{"key":"e_1_3_7_130_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177113"},{"key":"e_1_3_7_131_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1118593"},{"key":"e_1_3_7_132_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1413354"},{"key":"e_1_3_7_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62225-8"},{"key":"e_1_3_7_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.02.113"},{"key":"e_1_3_7_135_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1568159"},{"key":"e_1_3_7_136_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000516"},{"key":"e_1_3_7_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.03.107"},{"key":"e_1_3_7_138_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00430-13"},{"key":"e_1_3_7_139_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1111496"},{"key":"e_1_3_7_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.03.071"},{"key":"e_1_3_7_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.03.033"},{"key":"e_1_3_7_142_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1393335"},{"key":"e_1_3_7_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.03.066"},{"key":"e_1_3_7_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.07.008"},{"key":"e_1_3_7_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.09.076"},{"key":"e_1_3_7_146_1","unstructured":"Institut National de Sant\u00e9 Publique du Qu\u00e9bec (Comit\u00e9 sur l\u2019immunisation du Qu\u00e9bec). Scientific advisory on the optimal schedule for childhood immunization against pneumococcal disease in Qu\u00e9bec; [cited 2019 Oct 10]. Available from: https:\/\/www.inspq.qc.ca\/sites\/default\/files\/publications\/2379_opinion_optimal_schedule_childhood_immunization_pneumococcal_disease.pdf"},{"key":"e_1_3_7_147_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.04.005"},{"key":"e_1_3_7_148_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.03.001"},{"key":"e_1_3_7_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.10.007"},{"key":"e_1_3_7_150_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70822-9"},{"key":"e_1_3_7_151_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183191"},{"key":"e_1_3_7_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)00052-7"},{"key":"e_1_3_7_153_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161257"},{"key":"e_1_3_7_154_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.02.043"},{"key":"e_1_3_7_155_1","unstructured":"Joint Committee on Vaccination and Immunization (JCVI). Minute of the meeting on 04 October 2017; [cited 2019 Aug 23]. Available from: https:\/\/app.box.com\/s\/iddfb4ppwkmtjusir2tc\/file\/247634612957"},{"key":"e_1_3_7_156_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30654-0"},{"key":"e_1_3_7_157_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002845"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2020.1738226","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14760584.2020.1738226","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2020.1738226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:11:52Z","timestamp":1793722312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2020.1738226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,3]]},"references-count":155,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,3]]}},"alternative-id":["10.1080\/14760584.2020.1738226"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2020.1738226","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-12-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}